The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies today held a hearing on the Department of Health and Human Services’ funding request for fiscal year 2019. Chairman Roy Blunt (R-MO) expressed concern that the department’s proposal would eliminate funding for the Children’s Hospitals Graduate Medical Education program and the majority of health workforce training programs, among other priorities. “While I understand difficult choices had to be made, I believe it’s unlikely this subcommittee will support these eliminations.” Ranking Member Patty Murray (D-WA) said, “I want to make clear today that we will vigorously oppose any effort to undo the bipartisan deal the president signed into law.” Among hospital-specific comments, Sens. James Lankford (R-OK) and Brian Schatz (D-HI) emphasized the importance of adequate reimbursement and telehealth to rural hospitals, and Sen. Jerry Moran (R-KS) highlighted the importance of the 340B drug savings program to vulnerable hospitals and patients. Committee members also noted the effect the opioid epidemic has had on their states and expressed concern with rising drug prices. The president is expected to make a speech tomorrow afternoon outlining steps the administration will take to address drug pricing.

Headline
The AHA commented today on the Centers for Medicare & Medicaid Services’ proposed rule on the Global Benchmark for Efficient Drug Pricing Model, or…
Headline
The Administration for Strategic Preparedness and Response Feb. 18 announced an investment that will focus on resolving a frequent shortage of oseltamivir,…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the…
Headline
The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers…
Headline
The Department of Labor has issued a proposed rule to improve transparency of fees collected by pharmacy benefit managers. The rule requires PBMs to disclose…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…